Form 4: USCB Exec Logrono Granted 15,000 Restricted Shares

Sentiment:

Insider Transaction Report


USCB Financial Holdings' EVP and Chief Risk Officer, Maricarmen Logrono, received a grant of 15,000 restricted shares, vesting over three years.

Summary

  • Maricarmen Logrono, EVP and Chief Risk Officer of USCB Financial Holdings, Inc. (USCB), was granted 15,000 shares of restricted Class A Voting Common Stock.
  • The grant date for these restricted shares was January 27, 2026.
  • These 15,000 restricted shares will vest at a rate of one-third per year, with vesting commencing on January 27, 2027.
  • Following this transaction, Logrono's total beneficial ownership of Class A Voting Common Stock is 30,892 shares.
  • The 30,892 shares include 876 restricted shares from a grant that began vesting on January 22, 2025, 3,920 restricted shares from a grant that began vesting on January 21, 2026, and 6,217 restricted shares from the current 15,000 share grant, which will vest starting January 27, 2027.
  • Logrono also holds options to purchase 15,000 shares of Class A Voting Stock with an exercise price of $12.05.
  • These options were granted on September 27, 2022, and vest at one-third per year commencing on September 27, 2021, expiring on September 27, 2031.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term company performance and shareholder interests.

Positives

  • The grant of 15,000 restricted shares aligns management incentives with long-term shareholder value.
  • Increased beneficial ownership by a key executive demonstrates confidence in the company's future.

Risks

  • The value of the restricted stock and options is tied to the future performance of USCB's stock price, exposing the executive to market risk.
  • The vesting schedule means the executive's full ownership is contingent on continued employment and company performance over several years.

Future Outlook

The vesting schedules for the restricted stock and stock options extend several years into the future, indicating a long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that grants of restricted stock and stock options are standard practices in executive compensation across the financial services industry, aiming to align executive interests with long-term shareholder value. Such grants are common for key roles like Chief Risk Officer, reflecting their critical contribution to corporate stability and growth.

Comparison to Industry Standards

  • Executive compensation packages, including restricted stock and stock options, are typical across the financial sector.
  • For instance, similar grants are observed at regional banks like First Horizon Corporation or Cadence Bank, where executives receive equity awards tied to performance and tenure.
  • The vesting schedule of one-third per year over three years is a common structure designed to retain talent and incentivize sustained performance, comparable to practices at larger institutions like JPMorgan Chase or Bank of America for their senior leadership.

Stakeholder Impact

  • Shareholders: Potential for increased alignment of executive interests with shareholder value due to equity-based compensation.
  • Employees: May signal stability in executive leadership and a commitment to long-term incentives.

Next Steps

  • The 15,000 restricted shares will begin vesting at one-third per year starting January 27, 2027.
  • The 15,000 stock options will continue to vest at one-third per year, with an expiration date of September 27, 2031.

Key Dates

DateDescription
09/27/2021Commencement of vesting for 15,000 stock options.
09/27/2022Grant date for 15,000 stock options.
01/22/2025Commencement of vesting for a previous grant of 2,630 restricted shares.
01/21/2026Commencement of vesting for a previous grant of 5,880 restricted shares.
01/27/2026Grant date for 15,000 restricted shares to Maricarmen Logrono.
01/27/2027Commencement of vesting for the 15,000 restricted shares granted on 01/27/2026.
09/27/2031Expiration date for 15,000 stock options.

Recommendation

hold

This Form 4 filing details a routine executive compensation grant and does not provide sufficient new information to warrant a change in investment recommendation. It primarily serves as a disclosure of insider activity, which is generally expected and reflects standard corporate incentive practices. Investors should consider broader financial performance and market conditions for a comprehensive investment decision.

Keywords

USCB Financial Holdings, USCB, Form 4, Insider Transaction, Restricted Stock Grant, Stock Options, Executive Compensation, Maricarmen Logrono, EVP Chief Risk Officer, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.